Ledger.Open graph →
SEC Form D · Amendment · filed February 23, 2015

SELEXYS PHARMACEUTICALS CORP

Offering
$43.2M
Sold
$43.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OKLAHOMA CITY, OK
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Rodger Mcever, M.D · OKLAHOMA CITY, OKDirectorRichard Alvarez · Edmond, OKExecTodd Foley · Boston, MADirectorScott Rollins, Ph.D · OKLAHOMA CITY, OKExec · DirectorRussell Rother · OKLAHOMA CITY, OKExecPhilip Jones, M.D · Norman, OKDirectorDavid Falconer · Edmond, OKExecDavid Keiser · Madison, CTDirectorPhilip Jones, M.D · Norman, OKDirectorDavid Falconer · Edmond, OKExecAlain Reinhold · Dublin, IrelandDirectorJurg Schappi · Dublin, IrelandExecNicolas Motelay · Dublin, IrelandDirectorAleem Mawji · Stamford, CTExec · DirectorRandy Maksymowich · Calgary, Alberta, CanadaExec · DirectorMark Poelzer · Calgary, Alberta, CanadaExec · DirectorKevin Collings · Calgary, Alberta, CanadaExecJames Davis · Calgary, Alberta, CanadaDirectorPaul M. Britton · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗